VLKIM
EW icon

Van Lanschot Kempen Investment Management’s Edwards Lifesciences EW Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4M Sell
158,935
-12,420
-7% -$1.04M 0.11% 131
2026
Q1 		$13.7M Sell
171,355
-5,164
-3% -$426K 0.12% 125
2025
Q4 		$15M Buy
176,519
+44,219
+33% +$3.63M 0.13% 124
2025
Q3 		$10.3M Buy
132,300
+2,953
+2% +$231K 0.09% 158
2025
Q2 		$10.1M Sell
129,347
-93,227
-42% -$6.95M 0.1% 151
2025
Q1 		$16.1M Sell
222,574
-1,990
-0.9% -$142K 0.17% 115
2024
Q4 		$16.6M Sell
224,564
-73,191
-25% -$5.12M 0.17% 117
2024
Q3 		$19.6M Buy
297,755
+36,745
+14% +$2.67M 0.2% 113
2024
Q2 		$24.1M Buy
261,010
+36,901
+16% +$3.27M 0.27% 90
2024
Q1 		$21.4M Buy
+224,109
New +$18.8M 0.27% 94
2023
Q1 		– Sell
-13,132
Closed -$980K – 216
2022
Q4 		$980K Buy
13,132
+1,195
+10% +$92.1K 0.03% 171
2022
Q3 		$986K Sell
11,937
-3,802
-24% -$366K 0.04% 158
2022
Q2 		$1.5M Sell
15,739
-1,465
-9% -$152K 0.05% 152
2022
Q1 		$2.02M Buy
17,204
+2,493
+17% +$280K 0.06% 149
2021
Q4 		$1.91M Buy
+14,711
New +$1.72M 0.06% 141

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Van Lanschot Kempen Investment Management's EW Position: Q2 2026 in Review

Van Lanschot Kempen Investment Management reduced its Edwards Lifesciences (EW) stake by 7.2% in Q2 2026, selling an estimated $1.04M and leaving 158,935 shares worth $14.4M. The position accounts for 0.11% of the portfolio, ranked #131.

Van Lanschot Kempen Investment Management first reported a position in EW in Q4 2021 and has held it in 15 quarters since. The position peaked at $24.1M in Q2 2024. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Van Lanschot Kempen Investment Management held 158,935 shares of Edwards Lifesciences worth $14.4M as of Q2 2026.
  • Van Lanschot Kempen Investment Management sold 12,420 Edwards Lifesciences shares in Q2 2026, an estimated $1.04M.
  • Edwards Lifesciences made up 0.11% of Van Lanschot Kempen Investment Management's portfolio in Q2 2026, its #131 holding.
  • Van Lanschot Kempen Investment Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 15 quarters since.
  • Van Lanschot Kempen Investment Management's Edwards Lifesciences position peaked at $24.1M in Q2 2024.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.